Sr. Director, Infrastructure & Operations

• Bachelor’s degree in information technology, Computer Science, Engineering, or related discipline
• 12+ years of progressive IT experience with leadership responsibility across infrastructure and IT operations/service delivery
• Strong technical knowledge across Microsoft 365/Azure, identity and access, endpoint management, networking, cloud technologies, and enterprise IT operations
• Demonstrated experience building and scaling IT capabilities, teams, and operating models in a growing organization
• Experience supporting a geographically distributed or global organization
• Proven ability to lead internal teams and external service providers while maintaining clear internal ownership and accountability
• Strong operational judgment with a willingness to engage directly when needed
• Biotechnology, pharmaceutical, life sciences, or other regulated-industry experience preferred

Scholar Rock is seeking a Senior Director, Infrastructure & IT Operations to lead and scale the technology infrastructure and IT operations supporting our growing global organization.

Scholar Rock is looking for a leader who is equally comfortable building the roadmap and rolling up their sleeves to deliver it. This individual brings strong technical judgment, a high sense of ownership, and a service mindset and knows how to build an IT organization that is scalable as the company grows.

This is a hands-on leadership role responsible for the reliability, scalability, and day-to-day operation of Scholar Rock’s IT environment across the U.S. and international locations. The successful candidate will set direction, build and develop the team, and remain close enough to the technology and business to solve problems and drive execution.

This leader will strengthen the capabilities we need today while building the infrastructure and operating model required to support Scholar Rock’s continued growth and global commercialization.

Scholar Rock is delivering muscle-targeted breakthroughs to transform the treatment of spinal muscular atrophy (SMA) and other rare neuromuscular diseases where muscle atrophy remains a critical unmet need.

As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the biopharmaceutical company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity.

Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more about our neuromuscular franchise at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.